RxNorm Semantic Concepts Index - 471
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "471".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 471 | Aldose reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 471 | Aldose reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 471 | Aldose reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 471 | Aldose reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 471 | Aldose reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47102 | Nitrate reductase (NAD(P)H) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47102 | Nitrate reductase (NAD(P)H) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47102 | Nitrate reductase (NAD(P)H) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47111 | bifemelane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 471269 | HLA-B5701 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 471269 | HLA-B5701 antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 471269 | HLA-B5701 antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 471329 | Gamunex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 47155 | Diguanosinetetraphosphatase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47155 | Diguanosinetetraphosphatase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47155 | Diguanosinetetraphosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 471577 | Voluven | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 4716 | Gelatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 4716 | Gelatin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4716 | Gelatin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 4716 | Gelatin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4716 | Gelatin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 47178 | Bismuth citrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47178 | Bismuth citrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 4718 | Jelly | Dose Form (DF) | NO | |
| Concept ID (RxCUI): 4718 | Jelly | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47180 | bismuth tribromophenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 47181 | Colloidal bismuth subcitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 47181 | Colloidal bismuth subcitrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 47181 | Colloidal bismuth subcitrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 47181 | Colloidal bismuth subcitrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 47181 | Colloidal bismuth subcitrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 47181 | Colloidal bismuth subcitrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 47181 | Colloidal bismuth subcitrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 47187 | Bitolterol mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47187 | Bitolterol mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47187 | Bitolterol mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 47187 | Bitolterol mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4719 | Gemfibrozil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 4719 | Gemfibrozil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4719 | Gemfibrozil | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 4719 | Gemfibrozil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4719 | Gemfibrozil | Full form of descriptor (FN) | YES |